Literature DB >> 24900339

Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity.

Débora G Salomón1, Silvina M Grioli1, Maximiliano Buschiazzo1, Evangelina Mascaró2, Cristian Vitale2, Gabriel Radivoy2, Manuel Perez3, Yagamare Fall3, Enrique A Mesri4, Alejandro C Curino1, María M Facchinetti1.   

Abstract

Here, we describe the design and synthesis of diethyl [(5Z,7E)-(1S,3R)-1,3-dihydroxy-9,10-secochola-5,7,10(19)-trien-23-in-24-yl] phosphonate (compound 10), which combines the low calcemic properties of phosphonates with the decreased metabolic inactivation due to the presence of a triple bond in C-24 and studied its in vitro effects on several cancer cell lines and its in vivo effects on blood calcium levels. We demonstrate that this compound is a potent antiproliferative vitamin D analogue, showing lack of calcemic effects in vivo.

Entities:  

Keywords:  1α,25-(OH)2 vitamin D3; alkynylphosphonate analogues; cancer; cellular proliferation; hypercalcemia

Year:  2011        PMID: 24900339      PMCID: PMC4018101          DOI: 10.1021/ml200034w

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

Review 1.  New clues about vitamin D functions in the nervous system.

Authors:  Emmanuel Garcion; Nelly Wion-Barbot; Claudia N Montero-Menei; François Berger; Didier Wion
Journal:  Trends Endocrinol Metab       Date:  2002-04       Impact factor: 12.015

2.  Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.

Authors:  Sandra Reichrath; Cornelia S L Müller; Beate Gleissner; Michael Pfreundschuh; Thomas Vogt; Jörg Reichrath
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-04       Impact factor: 4.292

3.  Expression of VDR and CYP24A1 mRNA in human tumors.

Authors:  Mark G Anderson; Masaki Nakane; Xiaoan Ruan; Paul E Kroeger; J Ruth Wu-Wong
Journal:  Cancer Chemother Pharmacol       Date:  2005-09-23       Impact factor: 3.333

4.  The Stille Reaction of 1,1-Dibromo-1-alkenes: Preparation of Trisubstituted Alkenes and Internal Alkynes.

Authors:  Wang Shen; Le Wang
Journal:  J Org Chem       Date:  1999-11-26       Impact factor: 4.354

5.  Synthesis and biological activities of a new series of secosteroids: vitamin D phosphonate hybrids.

Authors:  A Steinmeyer; K Schwarz; M Haberey; G Langer; H Wiesinger
Journal:  Steroids       Date:  2001 Mar-May       Impact factor: 2.668

Review 6.  Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways.

Authors:  M R Uskokovic; A W Norman; P S Manchand; G P Studzinski; M J Campbell; H P Koeffler; A Takeuchi; M L Siu-Caldera; D S Rao; G S Reddy
Journal:  Steroids       Date:  2001 Mar-May       Impact factor: 2.668

Review 7.  Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.

Authors:  Donald L Trump; Kristin K Deeb; Candace S Johnson
Journal:  Cancer J       Date:  2010 Jan-Feb       Impact factor: 3.360

8.  Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.

Authors:  Britta Diesel; Jens Radermacher; Matthias Bureik; Rita Bernhardt; Markus Seifert; Jörg Reichrath; Ulrike Fischer; Eckart Meese
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

Review 9.  Calcitriol in cancer treatment: from the lab to the clinic.

Authors:  Tomasz M Beer; Anne Myrthue
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

10.  A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma.

Authors:  K Dalhoff; J Dancey; L Astrup; T Skovsgaard; K J Hamberg; F J Lofts; O Rosmorduc; S Erlinger; J Bach Hansen; W P Steward; T Skov; F Burcharth; T R J Evans
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

View more
  1 in total

1.  Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme.

Authors:  Débora G Salomón; María E Fermento; Norberto A Gandini; María J Ferronato; Julián Arévalo; Jorge Blasco; Nancy C Andrés; Jean C Zenklusen; Alejandro C Curino; María M Facchinetti
Journal:  J Neurooncol       Date:  2014-03-01       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.